Oppenheimer & Co’s Crescent Capital BDC CCAP Stock Holding History
Bought
Maintained
Sold
Other funds holding CCAP
TCDRS
FNF
SLF
AM
RCM
CC
Oppenheimer & Co's CCAP Position: Q2 2026 in Review
Oppenheimer & Co increased its Crescent Capital BDC (CCAP) stake by 24% in Q2 2026, buying an estimated $182K and bringing the position to 76,151 shares worth $832K. The position accounts for 0.01% of the portfolio, ranked #1019.
Oppenheimer & Co first reported a position in CCAP in Q1 2020 and has held it in 11 quarters since. The position peaked at $861K in Q4 2025. 85 funds tracked by Wall St. Rank hold CCAP as of Q2 2026.
- Oppenheimer & Co held 76,151 shares of Crescent Capital BDC worth $832K as of Q2 2026.
- Oppenheimer & Co bought 14,912 Crescent Capital BDC shares in Q2 2026, an estimated $182K.
- Crescent Capital BDC made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1019 holding.
- Oppenheimer & Co first reported a position in Crescent Capital BDC in Q1 2020 and has held it in 11 quarters since.
- Oppenheimer & Co's Crescent Capital BDC position peaked at $861K in Q4 2025.
- 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q2 2026.
Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.